These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2466035)
1. Tissue polypeptide antigen expression in human prostate tumors. Ghazizadeh M; Kagawa S; Oguro T; Takigawa H; Sasaki Y; Aihara K J Cancer Res Clin Oncol; 1989; 115(1):84-8. PubMed ID: 2466035 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of T antigen-like substance in benign hyperplasia and adenocarcinoma of the prostate. Ghazizadeh M; Kagawa S; Izumi K; Kurokawa K J Urol; 1984 Dec; 132(6):1127-30. PubMed ID: 6209422 [TBL] [Abstract][Full Text] [Related]
3. Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate. Ellis DW; Leffers S; Davies JS; Ng AB Am J Clin Pathol; 1984 Mar; 81(3):279-84. PubMed ID: 6199966 [TBL] [Abstract][Full Text] [Related]
4. Correlation of cell proliferation marker (TPS), natural killer (NK) activity and tumor load serotest (PSA) in untreated and treated prostatic tumors. Tarle M; Kovacić K; Kastelan M Anticancer Res; 1993; 13(1):215-8. PubMed ID: 7682800 [TBL] [Abstract][Full Text] [Related]
5. Tissue polypeptide antigen (TPA) as a prognostic aid in human prostatic carcinoma. Lewenhaupt A; Ekman P; Eneroth P; Nilsson B; Nordström L Prostate; 1985; 6(3):285-91. PubMed ID: 3991370 [TBL] [Abstract][Full Text] [Related]
6. TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49. Brenner PC; Rettig WJ; Sanz-Moncasi MP; Reuter V; Aprikian A; Old LJ; Fair WR; Garin-Chesa P J Urol; 1995 May; 153(5):1575-9. PubMed ID: 7536270 [TBL] [Abstract][Full Text] [Related]
7. Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material. Shah NT; Tuttle SE; Strobel SL; Gandhi L J Surg Oncol; 1985 Aug; 29(4):265-8. PubMed ID: 2417056 [TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical study of tissue polypeptide antigen (TPA) in human urinary bladder tumors]. Kaneko K; Suzuki T; Takasaki E Nihon Hinyokika Gakkai Zasshi; 1989 Oct; 80(10):1430-5. PubMed ID: 2601216 [TBL] [Abstract][Full Text] [Related]
9. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Sheridan T; Herawi M; Epstein JI; Illei PB Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190 [TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical study of the prostatic tissues with monoclonal antibody against gamma-seminoprotein. Analyses of benign prostatic hyperplasia, metastatic foci from adenocarcinoma of the prostate and malignant neoplasms other than adenocarcinoma of the prostate]. Fujino A; Shimura S; Murayama M; Ao T; Yokoyama E; Mashimo S; Ishibashi A; Koshiba K; Kuwao S Nihon Hinyokika Gakkai Zasshi; 1993 Mar; 84(3):527-34. PubMed ID: 7685842 [TBL] [Abstract][Full Text] [Related]
11. Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Nadji M; Tabei SZ; Castro A; Chu TM; Murphy GP; Wang MC; Morales AR Cancer; 1981 Sep; 48(5):1229-32. PubMed ID: 6168364 [TBL] [Abstract][Full Text] [Related]
12. Orbital metastasis from prostatic carcinoma. Identification by an immunoperoxidase technique. Winkler CF; Goodman GK; Eiferman RA; Yam LT Arch Ophthalmol; 1981 Aug; 99(8):1406-8. PubMed ID: 7020662 [TBL] [Abstract][Full Text] [Related]
13. Immunoelectron microscopic localization of prostatic-specific antigen in human prostate by the protein A-gold complex. Sinha AA; Wilson MJ; Gleason DF Cancer; 1987 Sep; 60(6):1288-93. PubMed ID: 2441840 [TBL] [Abstract][Full Text] [Related]
14. Prostatic origin of metastases: immunoperoxidase localization of prostate-specific antigen. Ghazizadeh M; Kagawa S; Maebayashi K; Izumi K; Kurokawa K Urol Int; 1984; 39(1):9-12. PubMed ID: 6203202 [TBL] [Abstract][Full Text] [Related]
16. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma]. Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496 [TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical identification of specific prostatic phosphatases and specific prostatic antigen in prostatic tumors]. Bonetti F; Pisa R; Chilosi M; Loddo G; Menestrina F; Zamboni G; Pea M Pathologica; 1983; 75(1040):789-95. PubMed ID: 6201809 [No Abstract] [Full Text] [Related]
18. Tissue polypeptide antigen (TPA) and prostatic acid phosphatase in serum of prostatic cancer patients. Huber PR; Rist M; Hering F; Biedermann C; Rutishauser G Urol Res; 1983; 11(5):223-6. PubMed ID: 6659214 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of carcinoembryonic antigen in benign hyperplasia and adenocarcinoma of the prostate with monoclonal antibody. Ghazizadeh M; Kagawa S; Izumi K; Maebayashi K; Takigawa H; Saiki T; Kawano A; Kurokawa K J Urol; 1984 Mar; 131(3):501-3. PubMed ID: 6199524 [TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen. Purnell DM; Heatfield BM; Trump BF Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]